These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies on abnormal hemoglobins. VI. Electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon. SINGER K; FISHER B Blood; 1953 Mar; 8(3):270-5. PubMed ID: 13032196 [No Abstract] [Full Text] [Related]
6. Studies on abnormal hemoglobins. III. The interrelationship of type S (sickle cell) hemoglobin and type F (alkali resistant) hemoglobin in sickle cell anemia. SINGER K; CHERNOFF AI Blood; 1952 Jan; 7(1):47-52. PubMed ID: 14886409 [No Abstract] [Full Text] [Related]
7. The effects of oxygen affinity and gelation of hemoglobin S crosslinked by reaction with methyl acetimidate. Chao TL; Berenfeld MR; Gelbart T; Gabuzda TG Hemoglobin; 1981; 5(1):47-72. PubMed ID: 7204094 [TBL] [Abstract][Full Text] [Related]
8. Nitrogen mustard: an "in vitro" inhibitor of erythrocyte sickling. Roth EF; Nagel RL; Bookchin RM; Grayzel AI Biochem Biophys Res Commun; 1972 Aug; 48(3):612-8. PubMed ID: 5047691 [No Abstract] [Full Text] [Related]
9. Dimethyl adipimidate: a new antisickling agent. Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514 [TBL] [Abstract][Full Text] [Related]
10. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes. Diederich D Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168 [No Abstract] [Full Text] [Related]
11. Prostaglandin E2 effects on oxygen affinity by sickle erythrocytes. Rabinowitz I; Wolf PL; Shikuma N; Berman S Prostaglandins; 1974 Aug; 7(4):309-17. PubMed ID: 4415346 [No Abstract] [Full Text] [Related]
12. Carbamyl phosphate modification of hemoglobin S structure resulting in altered sickling. Kraus LM; Rasad A; Kraus AP Adv Exp Med Biol; 1972; 28():279-96. PubMed ID: 5085172 [No Abstract] [Full Text] [Related]
13. Ultrastructural features of erythrocyte and hemoglobin sickling. White JG Arch Intern Med; 1974 Apr; 133(4):545-62. PubMed ID: 4594393 [No Abstract] [Full Text] [Related]
15. Inhibition of sickling in erythrocytes by amino acids. Rumen NM Blood; 1975 Jan; 45(1):45-8. PubMed ID: 803109 [TBL] [Abstract][Full Text] [Related]
16. The solubility of hemoglobin beta 4 S, the mutant subunits of sickle cell hemoglobin. Benesch R; Benesch RE; Yung S Biochem Biophys Res Commun; 1973 Nov; 55(2):261-5. PubMed ID: 4767302 [No Abstract] [Full Text] [Related]
17. Intermolecular contacts of deoxyhemoblogin S: a hypothesis and search for possible anti-sickling agents. Yang JT Biochem Biophys Res Commun; 1975 Mar; 63(1):232-8. PubMed ID: 1125014 [No Abstract] [Full Text] [Related]
18. Sickling-suppressive effects of chrysin may be associated with sequestration of deoxy-haemoglobin, 2,3-bisphosphoglycerate mutase, alteration of redox homeostasis and functional chemistry of sickle erythrocytes. Muhammad A; Waziri AD; Forcados GE; Sanusi B; Sani H; Malami I; Abubakar IB; Muhammad A; Muhammad RA; Mohammed HA Hum Exp Toxicol; 2020 Apr; 39(4):537-546. PubMed ID: 31876182 [TBL] [Abstract][Full Text] [Related]
19. Homoserine inhibition of in vitro sickling of erythrocytes. Kang SS; Benjamin G Exp Mol Pathol; 1975 Apr; 22(2):220-4. PubMed ID: 1116571 [No Abstract] [Full Text] [Related]
20. A temperature-dependent latent-period in the aggregation of sickle-cell deoxyhemoglobin. Malfa R; Steinhardt J Biochem Biophys Res Commun; 1974 Aug; 59(3):887-93. PubMed ID: 4411783 [No Abstract] [Full Text] [Related] [Next] [New Search]